The current price of AMLX is $29.40 — it has increased by 0.68% since the previous close. Data as of Nov 4, 2026.
AMLX is up 3.48% over the past week, up 5.79% over the past month and up 113.97% over the past year. The price is above its 200-day moving average of $20.23.
Analysts' average 12-month price target for AMLX is $52.20, which implies 77.55% upside from the current price. Individual estimates range from $42.00 to $57.00.
In its most recent quarterly report, Amylyx Pharmaceuticals, Inc. posted a loss of $0.39 per share against an estimate of -$0.3609, missing expectations by 8.06%. Upcoming reports are listed in the earnings calendar.
In the latest trading session AMLX moved between $27.90 and $30.65, a range of 9.35% of its current price.
Over the past 52 weeks AMLX has traded between $10.83 and $41.14. The current price is 28.54% below its 52-week high.
Figures as of Nov 4, 2026. This information is provided for general purposes only and is not investment advice.